As the COVID-19 pandemic continues to affect the healthcare system, the ability to more efficiently coordinate and deliver specialty-informed care is critical towards freeing up the higher acuity settings for patients who need it most during the pandemic.

AristaMD, a telehealth platform that delivers specialist insight to primary care physicians, is cashing in, and has just closed a $24 million Series B funding round. Brooke LeVasseur, CEO of AristaMD, joined Cheddar to discuss the value of the AristaMD eConsult platform and the benefits of a telehealth solution for patients who need timely care and lack sufficient access, especially during the COVID-19 pandemic.

Watch the interview: